High exposure to common antibiotics linked to Parkinson’s … Women, seniors have higher hypertension-associated atrial fibrillation risk … COPD death rates among North American women haven’t budged
Earlier onset, cognitive impairment raise mortality odds in Parkinson’s disease … Mortality risk competes with benefits of oral anticoagulants for A-Fib … Pacemakers improve heart function in chemotherapy-induced heart disease … Antibiotic-resistant infections causing nearly twice the deaths originally estimated: CDC
Wearable devices that use machine learning can accurately detect and rate Parkinson’s disease tremors outside the clinical setting.
People with newly diagnosed Parkinson’s who are taking multiple medications are at higher risk of cognitive decline, say Japanese researchers.
New strategy for Parkinson’s treatment tested … Metabolic dysfunction a primary cause of Alzheimer’s disease … Benefits of statins ‘marginal’ for most healthy people … Study reveals insight into how memory changes with age
Music enhances movement control in Parkinson’s … New clinical overview: Preventing and managing frailty … U.S. Senate hears expert testimony on falls prevention
A large-scale British trial is set to test whether cannabinoids can effectively treat hallucinations and delusions in Parkinson’s disease.
Parkinson’s disease symptoms can be monitored electronically while people go about their daily activities, according to a new proof-of-concept study.
Skin test designed to detect early Parkinson’s … Oral anticoagulant slows Alzheimer’s progression in mice … Oral capsule delivers injection-only drugs such as insulin
Risk of heart valve infections rising … Genetic markers linked to first symptoms of Parkinson’s … Discovery: A therapeutic target for healing aged muscles … 2 in 3 people think that dementia is a normal part of aging: Worldwide study
Next post in Clinical Daily News